Molecular heterogeneity regarding anti-PD-1/PD-L1 immunotherapy effectiveness will be linked together with tumour immune microenvironment inside Eastern side Asian individuals with non-small cellular carcinoma of the lung.
Molecular heterogeneity regarding anti-PD-1/PD-L1 immunotherapy effectiveness will be linked together with tumour immune microenvironment inside Eastern side Asian individuals with non-small cellular carcinoma of the lung.